Advisor Group Holdings, Inc. Veracyte, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 15,384 shares of VCYT stock, worth $683,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,384

Previous 16,982 9.41%

Holding current value

$683,049

Previous $367,000 42.51%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.0 - $35.25 $33,558 - $56,329	-1,598 Reduced 9.41%	15,384 $523,000
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $16,200 - $20,229	-859 Reduced 4.81%	16,982 $367,000
Q1 2024 May 10, 2024	SELL	$21.0 - $29.1 $172,263 - $238,707	-8,203 Reduced 31.5%	17,841 $395,000
Q4 2023 Feb 12, 2024	BUY	$19.72 - $28.68 $102,544 - $149,136	5,200 Added 24.95%	26,044 $716,000
Q3 2023 Nov 13, 2023	BUY	$22.33 - $29.92 $73,532 - $98,526	3,293 Added 18.76%	20,844 $465,000
Q2 2023 Aug 10, 2023	BUY	$20.96 - $26.99 $3,584 - $4,615	171 Added 0.98%	17,551 $447,000
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $8,767 - $11,881	426 Added 2.51%	17,380 $387,000
Q4 2022 Feb 10, 2023	BUY	$15.31 - $29.94 $110,369 - $215,837	7,209 Added 73.98%	16,954 $402,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $40,620 - $68,355	2,450 Added 33.58%	9,745 $162,000
Q2 2022 Aug 10, 2022	BUY	$15.45 - $29.52 $13,889 - $26,538	899 Added 14.06%	7,295 $145,000
Q1 2022 May 04, 2022	BUY	$21.94 - $42.51 $30,584 - $59,258	1,394 Added 27.87%	6,396 $166,000
Q3 2021 Nov 05, 2021	BUY	$35.62 - $52.97 $38,576 - $57,366	1,083 Added 27.63%	5,002 $233,000
Q2 2021 Aug 02, 2021	BUY	$32.94 - $56.62 $64,825 - $111,428	1,968 Added 100.87%	3,919 $157,000
Q1 2021 May 13, 2021	SELL	$44.47 - $81.38 $15,831 - $28,971	-356 Reduced 15.43%	1,951 $106,000
Q4 2020 Feb 10, 2021	SELL	$32.49 - $61.88 $423,474 - $806,543	-13,034 Reduced 84.96%	2,307 $112,000
Q3 2020 Nov 12, 2020	BUY	$26.73 - $35.67 $325,411 - $434,246	12,174 Added 384.4%	15,341 $499,000
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $20,990 - $30,274	1,077 Added 51.53%	3,167 $82,000
Q1 2020 May 18, 2020	BUY	$16.13 - $30.17 $33,711 - $63,055	2,090 New	2,090 $51,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.18B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Veracyte, Inc. Transaction History